Type 2 diabetes is rising among women in their 20s in England, with experts warning of a worrying increase since the Covid pandemic. The rise has...
AstraZeneca’s breast cancer drug Etcamah has been approved in the EU as part of a combination treatment for advanced disease. The European Commission acted on a...
Applications are still open for two of the most significant pitch opportunities in women’s health this year, but both deadlines are approaching fast. Pitch on the...
After more than two decades leading organisations at some of the world’s most respected medical device companies, including Hologic, SenoRx Breast Care, and BTL Industries, Joseph...
Addressing women’s health challenges through technology and innovation offers significant investment opportunities The intersection of women’s health and antifungal innovation represents a pivotal moment in healthcare,...
Menopause care remains fragmented and unequal worldwide, leaving many women without evidence-based support, a major review has found. The review identified significant gaps in care despite...
Pregnancy complications may increase women’s risk of peripheral artery disease later in life, new research suggests. The study analysed data from more than two million women...
Women with PMOS may have a fourfold higher risk of heart disease, new research suggests. PMOS, or polyendocrine metabolic ovarian syndrome, is a complex hormone condition...
A market analysis made by Moore Financial Consulting estimates the global market for Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the “Company” or...
Women newly diagnosed with breast cancer have a 59 per cent higher risk of ischaemic stroke in the first year after diagnosis, research suggests. Researchers also...
